Corcept Therapeutics Incorporated Stock Probability of Future Stock Price Finishing Over 43.14
| CORT Stock | USD 52.47 1.16 2.16% |
Corcept |
Corcept Therapeutics Target Price Odds to finish over 43.14
The tendency of Corcept Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 43.14 in 90 days |
| 52.47 | 90 days | 43.14 | under 95 |
Based on a normal probability distribution, the odds of Corcept Therapeutics to stay above $ 43.14 in 90 days from now is under 95 (This Corcept Therapeutics Incorporated probability density function shows the probability of Corcept Stock to fall within a particular range of prices over 90 days) . Probability of Corcept Therapeutics price to stay between $ 43.14 and its current price of $52.47 at the end of the 90-day period is about 48.82 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 suggesting Corcept Therapeutics Incorporated market returns are related to returns on the market. As the market goes up or down, Corcept Therapeutics is expected to follow. Additionally Corcept Therapeutics Incorporated has an alpha of 0.3232, implying that it can generate a 0.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Corcept Therapeutics Price Density |
| Price |
Predictive Modules for Corcept Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Corcept Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Corcept Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Corcept Therapeutics is not an exception. The market had few large corrections towards the Corcept Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Corcept Therapeutics Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Corcept Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.32 | |
β | Beta against Dow Jones | 1.04 | |
σ | Overall volatility | 5.38 | |
Ir | Information ratio | 0.12 |
Corcept Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Corcept Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Corcept Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 85.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Geode Capital Management LLC Purchases 99,470 Shares of Corcept Therapeutics Incorporated |
Corcept Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Corcept Stock often depends not only on the future outlook of the current and potential Corcept Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Corcept Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 111.7 M | |
| Cash And Short Term Investments | 368.2 M |
Corcept Therapeutics Technical Analysis
Corcept Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Corcept Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Corcept Therapeutics Incorporated. In general, you should focus on analyzing Corcept Stock price patterns and their correlations with different microeconomic environments and drivers.
Corcept Therapeutics Predictive Forecast Models
Corcept Therapeutics' time-series forecasting models is one of many Corcept Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Corcept Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Corcept Therapeutics
Checking the ongoing alerts about Corcept Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Corcept Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Over 85.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Geode Capital Management LLC Purchases 99,470 Shares of Corcept Therapeutics Incorporated |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.